Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
Eli Lilly(LLY) stock is priced at $1,162.50, giving the company a market capitalization of 1.09T. It carries a P/E multiple of 40.25 and pays a dividend yield of 0.56%.
On 2026-09-30, Eli Lilly(LLY) stock traded between a low of $1,155.27 and a high of $1,214.99. Shares are currently priced at $1,162.50, which is +0.6% above the low and -4.3% below the high.
The Eli Lilly(LLY)'s current trading volume is 3.4M, compared to an average daily volume of 2.49M.
During the past year, Eli Lilly(LLY) stock moved between $725.31 at its lowest and $1,292.65 at its peak.
During the past year, Eli Lilly(LLY) stock moved between $725.31 at its lowest and $1,292.65 at its peak.
LLY News
These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Amazon In New Base 9/30/2026 Among the best stocks in earnings performance, highly rated...
Pharmaceutical giant Eli Lilly and Co. (NYSE:LLY) reported positive data from two late-stage clinical trials, showcasing substantial progress in treatments for...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Eli Lilly And Company (LLY) is running a Phase 2b study called “A Study of Cla...
Analyst ratings
84%
of 32 ratingsMore LLY News
Key Points TRIUMPH-2 contains retatrutide, a triple agonist weight loss drug. Triple-agonist drugs attempt to suppress appetite, lower blood sugar, and increa...
Eli Lilly’s (LLY) stock is rising on Sept. 30 after the pharmaceutical giant reported that “EloraTZP,” a combination regimen containing its popular weight-loss...
(RTTNews) - Eli Lilly and Company (LLY) said on Wednesday that its investigational EloraTZP combination of eloralintide and tirzepatide delivered substantial we...
In the race to come up with newer and better weight-loss drugs, Eli Lilly appears to have found a powerful combination. The pairing of a promising new drug wit...
Eli Lilly (LLY) announced “positive” results from a Phase 2b trial evaluating the safety and efficacy of EloraTZP. Eloralintide alone reduced body weight by up...
...
Lilly signage during a groundbreaking ceremony for Eli Lilly and Company's pharmaceutical manufacturing campus at Generation Park in Houston, Texas, US, on Mond...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.